| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $634K | — |
| SG&A Expense | $1.5M | +1067.5% |
| Operating Income | -$7.1M | -29.0% |
| Pre-tax Income | -$10.6M | -71.6% |
| Net Income | -$10.6M | -71.6% |
| EPS (Basic) | -$0.22 | +31.3% |
| EPS (Diluted) | -$0.22 | +31.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | — |
| Current Assets | $7.3M | +4521.8% |
| Total Assets | $9.6M | +290.4% |
| Current Liabilities | $77K | -93.8% |
| Total Liabilities | $130K | -89.8% |
| Stockholders' Equity | $9.5M | +698.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -99.9% |
| Investing Cash Flow | -$123K | +0.0% |
| Financing Cash Flow | $13.0M | +315.3% |